Synthetic β-sheet forming peptide amphiphiles for treatment of fungal keratitis

Biomaterials

Volumn 43, Issue 1, 2015, Pages 44-49

  Wu, Hong ^a   Ong, Zhan Yuin ^a   Liu, Shaoqiong ^a   Li, Yan ^a   Wiradharma, Nikken ^a   Yang, Yi Yan ^a   Ying, Jackie Y ^a  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

Author keywords

Anti biofilm; Antibiotics resistance; Antifungal; Fungal keratitis; sheet forming peptide

Indexed keywords

ANTIBIOTICS; ANTIMICROBIAL AGENTS; BACTERIA; ESCHERICHIA COLI; MICROORGANISMS; PEPTIDES; POLYPEPTIDES; YEAST;

ANTI-BIOFILM; ANTI-FUNGAL; ANTIBIOTICS RESISTANCE; FUNGAL KERATITIS; SHEET FORMING;

FUNGI;

AMPHOPHILE; AMPHOTERICIN B; POLYPEPTIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; PEPTIDE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; BETA SHEET; BIOMASS; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; ESCHERICHIA COLI; FUNGUS GROWTH; IN VITRO STUDY; IN VIVO STUDY; KERATOMYCOSIS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; ANIMAL; ANTIBIOTIC RESISTANCE; BIOFILM; C57BL MOUSE; CELL SURVIVAL; CHEMISTRY; CONTACT LENS; DRUG EFFECTS; HUMAN; KERATITIS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROTEIN SECONDARY STRUCTURE;

BACTERIA (MICROORGANISMS); CANDIDA ALBICANS; ESCHERICHIA COLI; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

AMPHOTERICIN B; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BIOFILMS; BIOMASS; CANDIDA ALBICANS; CELL SURVIVAL; CONTACT LENSES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HUMANS; KERATITIS; MICE; MICE, INBRED C57BL; MICROBIAL SENSITIVITY TESTS; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84923055886     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.11.052     Document Type: Article

References (22)

1. Imamura Y., Chandra J., Mukherjee P.K., Lattif A.A., Szczotka-Flynn L.B., Pearlman E., et al. Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions. Antimicrobial Agents Chemother 2008, 52:171-182.
2. Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol 2004, 15:321-327.
3. Alfonso E.C., Cantu-Dibildox J., Munir W.M., Miller D., O'Brien T.P., Karp C.L., et al. Insurgence of Fusarium keratitis associated with contact lens wear. Arch Ophthalmol 2006, 124:941-947.
4. Alfonso E.C., Miller D., Cantu-Dibildox J., O'Brien T.P., Schein O.D. Fungal keratitis associated with non-therapeutic soft contact lenses. Am J Ophthalmol 2006, 142:154-155.
5. Khor W.B., Aung T., Saw S.M., Wong T.Y., Tambyah P.A., Tan A.L., et al. An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. JAMA 2006, 295:2867-2873.
6. Saw S.M., Ooi P.L., Tan D.T., Khor W.B., Fong C.W., Lim J., et al. Risk factors for contact lens-related Fusarium keratitis: a case-control study in Singapore. Arch Ophthalmol 2007, 125:611-617.
7. Gaujoux T., Chatel M.A., Chaumeil C., Laroche L., Borderie V.M. Outbreak of contact lens-related Fusarium keratitis in France. Cornea 2008, 27:1018-1021.
8. Ma S.K., So K., Chung P.H., Tsang H.F., Chuang S.K. Amulti-country outbreak of fungal keratitis associated with a brand of contact lens solution: the Hong Kong experience. Int J Infect Dis 2009, 13:443-448.
9. Chang D.C., Grant G.B., O'Donnell K., Wannemuehler K.A., Noble-Wang J., Rao C.Y., et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA 2006, 296:953-963.
10. Wu T.G., Wilhelmus K.R., Mitchell B.M. Experimental keratomycosis in a mouse model. Invest Ophthalmol Vis Sci 2003, 44:210-216.
11. Kalkanci A., Ozdek S. Ocular fungal infections. Curr Eye Res 2011, 36:179-189.
12. Dupuis A., Tournier N., Le Moal G., Venisse N. Preparation and stability of voriconazole eye drop solution. Antimicrobial Agents Chemother 2009, 53:798-799.
13. Ganegoda N., Rao S.K. Antifungal therapy for keratomycoses. Expert Opin Pharmacother 2004, 5:865-874.
14. Frei R., Breitbach A.S., Blackwell H.E. 2-Aminobenzimidazole derivatives strongly inhibit and disperse Pseudomonas aeruginosa biofilms. Angew Chem Int Ed Engl 2012, 51:5226-5229.
15. Sheehan D.J., Hitchcock C.A., Sibley C.M. Current and emerging azole antifungal agents. Clin Microbiol Rev 1999, 12:40-79.
16. Yolton D.P., Haesaert S.P. Polyene antifungal drugs. Clinical ocular pharmacology 2008, 208. Elsevier, St. Louis. J.D. Bartlett, S.D. Jaanus (Eds.).
17. Keay L., Edwards K., Naduvilath T., Taylor H.R., Snibson G.R., Forde K., et al. Microbial keratitis: predisposing factors and morbidity. Ophthalmology 2006, 113:109-116.
18. Hancock R.E., Sahl H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 2006, 24:1551-1557.
19. Eckert R. Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development. Future Microbiol 2011, 6:635-651.
20. Ong Z.Y., Gao S.J., Yang Y.Y. Short synthetic β-sheet forming peptide amphiphiles as broad spectrum antimicrobials with antibiofilm and endotoxin neutralizing capabilities. Adv Funct Mater 2013, 23:3682-3692.
21. Goldblum, Frueh B.E., Sarra G.M., Katsoulis K., Zimmerli S. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model. Antimicrobial Agents Chemother 2005, 49:1359-1363.
22. Revankar SG, Sobel JD, Antifungal drugs, Online 2014, Available from URL:. http://www.merckmanuals.com/professional/infectious_diseases/fungi/antifungal_drugs.html.